Kevin Craig
Chief Tech/Sci/R&D Officer bei ATAI LIFE SCIENCES N.V.
Profil
Kevin Craig is currently working as Vice President-Clinical Development at ATAI Life Sciences NV since 2021.
Prior to this, he worked as Senior Director-Neuroscience at Labcorp Drug Development, Inc. and as Head-Early Clinical Development at Jazz Pharmaceuticals, Inc. Dr. Craig has a graduate degree from the University of Cambridge and the University of the Witwatersrand.
Aktive Positionen von Kevin Craig
| Unternehmen | Position | Beginn |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | Chief Tech/Sci/R&D Officer | 01.01.2021 |
Ehemalige bekannte Positionen von Kevin Craig
| Unternehmen | Position | Ende |
|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Ausbildung von Kevin Craig
| University of Cambridge | Graduate Degree |
| University of the Witwatersrand | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
